KAMURAImmune & cellular health / VISUAL FIELD GUIDE
FOXO4-DRI
FOXO4-DRI is a research senolytic peptide. It is intended to alter survival signalling in senescent cells, with no established client anti-ageing outcome.
01 / FOLLOW THE BIOLOGY
From signal to response.
Schematic explanation · not a measured treatment response
STEP 1 OF 3
Protein interaction
Two proteins help regulate cell survival.
What are you trying to understand?
Choose a concern to see the research context. A symptom is a starting point for assessment, not a treatment selection.
Experimental research
Cellular senescence
Studies investigate FOXO4–p53 interactions and senescent-cell responses.
Examine the supporting research ↓The details that change the interpretation.
Formulation & route
Research peptide exposure does not establish a therapeutic human regimen.
Bring to the discussion
Is there a controlled human outcome study for this agent?
Go beyond the summary.
0102
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI.
pubmed.ncbi.nlm.nih.gov · Open source ↗FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway.
pubmed.ncbi.nlm.nih.gov · Open source ↗More research already linked in Kamura (3)
FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway. · 2025